# A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

> **NCT03356977** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 137 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Crisaborole ointment 2%

## Key facts

- **NCT ID:** NCT03356977
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-16
- **Primary completion:** 2019-04-12
- **Final completion:** 2019-04-12
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03356977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03356977, "A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03356977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*